laboratory employee

AmazonPharma Services

AmazonPharma services include Compliance to Regulations, Personnel Management, Development & Coaching, Cultural Change and Pharmaceutical Lean Manufacturing. Whether you are looking for a complete package or you need urgent solution for specific task, our experienced consultants can assist you. You know, that getting the right balance between compliance and efficiency is a very challenging task. Many organisations struggle to get it right and often levelling between success or failure. We will ensure that you manufacture safe products, while committed to assist you to achieve business goal and maximise return on your investment.

We have a lot to offer!

Organisations need to be profitable, sustainable and innovative to survive. To achieve this manufacturing facilities need to:

be Regulatory compliant

have consistent and robust systems, equipment and processes

have Continuous improvement programs to challenge 'the way we do things'

have talented, dedicated, positive and “can do” attitude employees and create environment to retain those employees

To assist you in achieving that AmazonPharma offering following services and training:

GMP Services

Human Resource Services

Pharmaceutical Lean Manufacturing

Human Error and the Pharmaceutical Industry

Please contact us to find out how we can help you!

Secondary Navigation

Placebo fraud

(Natural News) You know all those thousands of clinical trials conducted over the last few decades comparing pharmaceuticals to placebo pills? Well, it turns out...

The Pharmaceutical Industry in Australia

The extent to which companies can supply medicines to Australian pharmaceutical markets is governed by the operations of two government agencies. The authority regulating whether a medicine can be sold in Australia is the Therapeutic Goods
Administration (TGA) and its operations are described in terms of the regulatory approvals process and compared to the equivalent organisations in the USA and Europe.

Continue Reading »

FDA consider reclassifying some prescription drugs as OTC

On March 22 and 23, 2012, the U.S. Food and Drug Administration (FDA) will be holding a public hearing to determine a general opinion about whether certain drugs that currently require a prescription should be reclassified as a non prescription product if the medication will be used under certain conditions of safe use for that drug.